CONMED Corporation
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $40.8M | $24.5M | $24.3M | $28.9M | $20.8M | $27.4M | $25.9M | $17.5M |
| Accounts Receivable | $247.8M | $237.7M | $242.3M | $191.3M | $183.9M | $177.2M | $189.1M | $181.6M |
| Inventory | $355.5M | $346.7M | $318.3M | $332.3M | $231.6M | $194.9M | $164.6M | $154.6M |
| Total Current Assets | $672.9M | $640.0M | $615.6M | $581.2M | $460.1M | $416.7M | $397.4M | $374.4M |
| Property, Plant & Equipment | $113.3M | $115.8M | $120.7M | $115.6M | $108.9M | $111.4M | $118.9M | $113.2M |
| Goodwill | $807.0M | $805.4M | $806.8M | $815.4M | $617.5M | $618.4M | $618.0M | $400.4M |
| Intangible Assets (Excl. Goodwill) | $582.1M | $617.7M | $649.5M | $681.8M | $471.0M | $501.5M | $532.8M | $413.2M |
| Total Assets | $2.33B | $2.31B | $2.30B | $2.30B | $1.77B | $1.75B | $1.78B | $1.37B |
| Liabilities | ||||||||
| Accounts Payable | $93.6M | $102.2M | $88.2M | $73.4M | $58.2M | $53.3M | $56.0M | $53.5M |
| Total Current Liabilities | $315.0M | $278.1M | $310.7M | $296.6M | $196.6M | $190.2M | $188.1M | $160.9M |
| Long-Term Debt | $834.2M | $905.1M | $973.1M | $985.1M | $672.4M | $735.2M | $755.2M | $438.6M |
| Total Liabilities | $1.29B | $1.34B | $1.47B | $1.55B | $980.6M | $1.04B | $1.06B | $706.9M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $588.8M | $560.3M | $452.5M | $412.6M | $496.6M | $457.4M | $470.8M | $464.9M |
| Total Stockholders' Equity | $1.03B | $962.7M | $834.2M | $745.5M | $785.4M | $709.0M | $710.5M | $662.3M |